ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	40/642	73/6026	8.61753058483126e-21	4.1622672724735e-18	3.3744435553234e-18	6356/6357/6361/6362/6347/6364/6370/10344/6348/6351/9560/1437/1440/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3586/3589/3605/29949/3552/3553/3557/51561/11009/3569/4312/4314/4318/5008/5196/6696/7124	40
WP5055	Burn wound healing	37/642	97/6026	6.70245349066507e-13	1.36891635702641e-10	1.10981123420252e-10	8038/6347/57124/1277/1278/2919/3579/2162/2200/3082/3383/3552/3553/3569/3624/3853/23643/440823/4312/4322/4313/4314/4318/64332/64127/5159/6282/6280/6423/6678/7042/7043/7076/7097/51311/3371/7124	37
WP5115	Network map of SARS-CoV-2 signaling pathway	55/642	189/6026	8.50258606848701e-13	1.36891635702641e-10	1.10981123420252e-10	59272/183/335/341/8542/684/715/838/6356/6347/6364/10344/6348/6351/1234/1051/629/3426/5199/1294/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/3091/10964/8519/10410/3458/3586/3605/8807/3552/3553/3569/3699/3726/116844/64386/114548/4939/5196/5743/6288/6289/6403/5054/6772/7124	55
WP2806	Complement system	30/642	75/6026	2.61045343356489e-11	3.1521225210296e-09	2.55549651917405e-09	133/335/715/717/720/722/728/27202/958/1604/22918/629/3426/5199/2162/2214/2219/2357/2769/3383/3687/3689/5648/5329/6401/6402/6403/710/6696/7097	30
WP4891	COVID-19 adverse outcome pathway	11/642	13/6026	1.18419558907171e-09	1.14393293904327e-07	9.27412124494051e-08	59272/183/6347/6348/1440/3627/3586/3553/3559/3569/7124	11
WP3624	Lung fibrosis	22/642	52/6026	3.48647272578983e-09	2.80661054426081e-07	2.27538219998915e-07	6356/6347/6348/6351/1232/1051/1215/1437/1440/2920/57105/2252/26585/3082/3553/3569/4313/4318/5328/6696/7076/7124	22
WP691	Tamoxifen metabolism	12/642	17/6026	7.25872006300768e-09	5.0085168434753e-07	4.06051708787798e-07	1545/1557/1558/1559/1565/1576/2326/2328/6783/6822/54657/7364	12
WP619	Type II interferon signaling	17/642	34/6026	9.78445536439446e-09	5.90736492625315e-07	4.7892334152036e-07	4261/3627/4283/2633/3383/3433/3458/3553/3659/9636/4843/5698/8651/9021/6688/6772/6890	17
WP5088	Prostaglandin signaling	15/642	28/6026	2.19794098169942e-08	1.14576489793736e-06	9.28897334712208e-07	834/6347/6348/2919/3627/4283/3458/3605/3552/3553/3569/4318/114548/9536/7124	15
WP2882	Nuclear receptors meta-pathway	59/642	268/6026	2.37218405370053e-08	1.14576489793736e-06	9.28897334712208e-07	5243/1244/64240/64241/51129/335/345/8553/330/874/6347/6364/1545/1555/1557/1559/1576/1551/1907/9982/2938/2939/1839/3082/3458/3589/3553/3726/23764/4199/8431/9971/9970/5142/5743/6286/6319/5272/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/8140/5552/27286/2040/6822/7042/7056/7124/54657/7364	59
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	23/642	62/6026	3.11262399040989e-08	1.36672489760725e-06	1.10803456883491e-06	59272/6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3433/8519/3586/3569/3902/5196/6772/7124	23
WP2865	IL1 and megakaryocytes in obesity	13/642	23/6026	8.42655044760238e-08	3.39168655515996e-06	2.7497164618492e-06	6347/1232/2205/1839/3383/3458/3553/4318/114548/7941/6280/7076/7097	13
WP455	GPCRs, class A rhodopsin-like	33/642	118/6026	1.05573767521236e-07	3.92247151636593e-06	3.18003575043724e-06	51554/134/27202/1230/2826/1232/1234/1237/10803/3577/3579/57105/1909/2151/2867/2357/2358/29909/2828/8111/8843/3274/3352/4543/64106/4888/53829/5031/5724/5737/5739/6752/56670	33
WP2328	Allograft rejection	25/642	76/6026	1.24139418757474e-07	4.28280994713287e-06	3.47217020885568e-06	5243/717/720/721/958/1604/941/1493/6373/4283/50943/10578/3002/3119/3134/3458/3586/3605/3552/3553/3559/120892/5551/6772/7124	25
WP5198	Inflammatory bowel disease signaling	16/642	35/6026	1.33675541069652e-07	4.3043524224428e-06	3.48963517739724e-06	50943/3458/3586/3594/3595/8807/3552/50615/51561/3569/4094/64127/6772/30009/7097/7124	16
WP129	Matrix metalloproteinases	13/642	24/6026	1.66070703662628e-07	5.01325936681557e-06	4.06436195805904e-06	4312/4319/4321/4322/4327/4313/10893/64386/4314/4316/4318/7076/7124	13
WP1533	Vitamin B12 metabolism	16/642	37/6026	3.45283809029896e-07	9.79043020555119e-06	7.93732164425203e-06	335/338/875/6347/8029/3383/3458/3553/3569/3949/6288/6289/5054/6648/6947/7124	16
WP3617	Photodynamic therapy-induced NF-kB survival signaling	15/642	33/6026	3.64860753001908e-07	9.79043020555119e-06	7.93732164425203e-06	597/330/1437/2920/3383/3552/3553/3569/4312/4313/4314/4318/5743/6401/7124	15
WP4754	IL-18 signaling pathway	51/642	239/6026	6.229851319708e-07	1.51347005232631e-05	1.22700416141525e-05	321/467/330/6362/6347/6364/6348/6351/1051/9076/24146/6900/1277/1278/1281/2920/2921/338442/3383/3458/3586/8807/3553/3559/3569/3659/3801/4312/4322/4313/4314/4318/4688/64332/4843/8431/7941/5743/6004/8698/9021/6696/30009/7052/7076/7124/7127/4982/79931/7185/80149	51
WP530	Cytokines and inflammatory response	11/642	19/6026	6.2669567384112e-07	1.51347005232631e-05	1.22700416141525e-05	1437/1440/2919/2920/3458/3586/3589/3552/3553/3569/7124	11
WP15	Selenium micronutrient network	20/642	59/6026	1.33617040138572e-06	3.07319192318715e-05	2.49150571085457e-05	240/335/338/875/6347/1734/3383/3458/3553/3569/8564/8942/3949/5743/6288/6289/5054/6648/7124/7498	20
WP2877	Vitamin D receptor pathway	35/642	143/6026	1.46755649330343e-06	3.22195357393435e-05	2.61211012205204e-05	5243/240/248/768/838/875/958/634/1493/1594/1555/1559/1565/1576/168002/1673/50486/3091/3488/3726/5653/639/6273/6279/6280/10568/6696/6699/79689/412/6822/7042/7056/4982/54210	35
WP4462	Platelet-mediated interactions with vascular and circulating cells	10/642	17/6026	1.70671313527002e-06	3.58409758406704e-05	2.90570840421257e-05	6347/958/3383/3553/5196/6401/6403/7042/7043/7097	10
WP24	Peptide GPCRs	16/642	41/6026	1.8343794276629e-06	3.69168859817158e-05	2.99293485566051e-05	728/1230/2826/1232/1234/1237/10803/3577/3579/10663/1909/2357/2358/4888/6752/7253	16
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/642	24/6026	1.25270168047332e-05	0.000234229715723125	0.000189895290942579	6348/6351/1230/1232/1234/1437/3458/3594/3595/7042/7043	11
WP702	Metapathway biotransformation Phase I and II	30/642	125/6026	1.26086389416175e-05	0.000234229715723125	0.000189895290942579	50515/9435/9469/1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420/2326/2327/2328/92292/2938/2939/9027/4837/6783/6822/54657/79799/7364	30
WP43	Oxidation by cytochrome P450	14/642	38/6026	1.78124839365412e-05	0.000318645545975903	0.000258333100366211	1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420	14
WP5218	Extrafollicular B cell activation by SARS-CoV-2	19/642	65/6026	2.78407739793159e-05	0.000480253351143199	0.000389352177455094	720/958/941/83416/29851/3433/8519/3458/3586/3569/9636/3687/3689/4094/639/6402/57823/30009/7124	19
WP5090	Complement system in neuronal development and plasticity	23/642	93/6026	7.8693605508241e-05	0.00131065556760277	0.00106257790377734	715/717/720/721/722/725/728/27202/843/1604/629/3426/5199/10584/2219/8547/3458/3687/3689/5648/710/7042/7043	23
WP2876	Pregnane X receptor pathway	11/642	29/6026	0.000105295065715552	0.00169525055802038	0.00137437769986615	5243/1244/1555/1557/1559/1576/1551/2939/27286/6822/54657	11
WP430	Statin inhibition of cholesterol production	10/642	25/6026	0.000129421665664085	0.00195345826611728	0.00158371248773156	64240/64241/335/337/338/341/345/3949/4547/6713	10
WP5092	Interactions of natural killer cells in pancreatic cancer	10/642	25/6026	0.000129421665664085	0.00195345826611728	0.00158371248773156	6347/6348/6351/1437/2214/3002/3458/4277/5551/7124	10
WP2289	Drug induction of bile acid pathway	7/642	13/6026	0.000145524866378281	0.00212995486244574	0.00172680224219204	5243/1244/1576/9971/9970/200931/6822	7
WP2431	Spinal cord injury	23/642	98/6026	0.000184856952342835	0.00256698074298755	0.00208110893841423	301/63827/6347/50515/1282/2919/3627/2920/2212/3383/3458/3552/3553/3569/10288/11025/4321/4318/4843/5320/5743/6403/7124	23
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	18/642	68/6026	0.000186013097317939	0.00256698074298755	0.00208110893841423	6347/958/1594/1673/10964/3458/3569/9636/5600/6300/64127/4939/91543/6258/6772/7097/51311/7124	18
WP1604	Codeine and morphine metabolism	6/642	10/6026	0.000205955274809574	0.00276323327036179	0.00224021526985853	5243/1244/1558/1565/1576/7364	6
WP2911	miRNA targets in ECM and membrane receptors	9/642	22/6026	0.000231350782729394	0.00302006562319723	0.00244843502632531	1278/1281/1282/1284/1290/50509/1291/1293/7058	9
WP545	Complement activation	8/642	18/6026	0.000262737633219994	0.00330874018369349	0.0026824699756652	715/717/720/721/1604/629/5199/5648	8
WP2875	Constitutive androstane receptor pathway	10/642	27/6026	0.000274015750202359	0.00330874018369349	0.0026824699756652	5243/1244/1555/1557/1559/1576/2939/9970/6822/54657	10
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	10/642	27/6026	0.000274015750202359	0.00330874018369349	0.0026824699756652	59272/6347/2939/3553/3569/4312/4314/5593/23657/7124	10
WP117	GPCRs, other	12/642	37/6026	0.000289254857169251	0.0034075633173841	0.00276258810954971	27202/1234/3577/3579/1909/29933/11245/53831/59340/53829/5737/6752	12
WP176	Folate metabolism	14/642	48/6026	0.000322723949458835	0.00358285171198803	0.00290469834773793	335/338/875/6347/3383/3458/3553/3569/3949/6288/6289/5054/6648/7124	14
WP558	Complement and coagulation cascades	14/642	48/6026	0.000322723949458835	0.00358285171198803	0.00290469834773793	715/717/721/728/1604/629/3426/5648/5328/5329/5054/710/7056/7450	14
WP2880	Glucocorticoid receptor pathway	17/642	65/6026	0.000326388147675928	0.00358285171198803	0.00290469834773793	51129/8553/330/6347/6364/1907/9982/3589/8972/9970/5142/5743/6286/5272/5552/2040/7056	17
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/642	28/6026	0.000386124876975067	0.00414440701286572	0.00335996384174795	6347/29126/941/1493/3627/3559/8651/7042/7043/51311	10
WP5174	Ulcerative colitis signaling	7/642	15/6026	0.000450538548600151	0.00473065476030158	0.00383524805673355	50943/3458/3586/4094/64127/7097/7124	7
WP4329	miRNAs involvement in the immune response in sepsis	12/642	39/6026	0.000499916109988796	0.00503040585676226	0.00407826300254018	6348/6351/3002/3383/3586/3552/3569/3659/3934/407008/51311/7124	12
WP5097	CCL18 signaling pathway	12/642	39/6026	0.000499916109988796	0.00503040585676226	0.00407826300254018	467/1237/1278/1437/3091/440823/4313/4318/6615/6772/7291/652995	12
WP2848	Pluripotent stem cell differentiation pathway	11/642	34/6026	0.000529169939806121	0.00521610369237462	0.00422881240833248	3577/22943/2255/3082/3589/3569/3624/6469/7043/7472/7474	11
WP5094	Orexin receptor pathway	24/642	112/6026	0.000576682512802971	0.0055707530736767	0.00451633462658327	8553/2920/1734/1846/1959/1960/1839/3091/3383/3586/3553/3569/3726/3949/23764/4322/4314/64106/8013/5069/6401/6696/3371/7124	24
WP167	Eicosanoid synthesis	8/642	20/6026	0.000623030726444013	0.00590046746808742	0.00478364149096332	246/240/1800/5320/80339/5730/9536/5743	8
WP4969	RAS and bradykinin pathways in COVID-19	9/642	25/6026	0.000708225248541146	0.0065783229816418	0.0053331941792977	1636/59272/183/1576/3552/3553/5054/710/7124	9
WP299	Nuclear receptors in lipid metabolism and toxicity	9/642	26/6026	0.000982328179385583	0.00878637982672661	0.00712331545285452	5243/1244/64240/1594/1555/1559/1576/9971/9970	9
WP453	Inflammatory response pathway	9/642	26/6026	0.000982328179385583	0.00878637982672661	0.00712331545285452	958/941/1277/1278/1281/3458/3559/3568/3918	9
WP75	Toll-like receptor signaling pathway	19/642	84/6026	0.00106590639251095	0.00936059613786888	0.00758884551223106	6348/6351/958/941/3627/6373/4283/3553/3569/23643/1326/5600/6300/8503/6696/6772/7097/51311/7124	19
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	11/642	37/6026	0.00117422634381596	0.0101277022154126	0.00821075563720932	84674/834/838/50506/3553/4210/91662/114548/199713/64127/639	11
WP4724	Omega-9 fatty acid synthesis	6/642	13/6026	0.0012697122908058	0.0107591409905123	0.00872267723323655	2180/2182/54898/3992/9415/6319	6
WP465	Tryptophan metabolism	10/642	33/6026	0.00166399181055191	0.0137005749741406	0.0111073638234288	8854/316/1545/1562/1576/9420/3620/8942/4129/6999	10
WP5033	Genes associated with the development of rheumatoid arthritis	7/642	18/6026	0.00167356919973974	0.0137005749741406	0.0111073638234288	958/4261/1493/3559/23569/6583/7185	7
WP697	Estrogen metabolism	6/642	14/6026	0.00202367318151928	0.0162905691112302	0.0132071302372837	1545/1576/2938/412/6783/7364	6
WP716	Vitamin A and carotenoid metabolism	10/642	34/6026	0.00213683425669598	0.0169195237046584	0.0137170378514393	64240/64241/8854/1381/1382/56603/9227/29881/5948/6258	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	6/642	15/6026	0.00307242960346536	0.0239352177173188	0.0194048185482023	335/338/3949/9388/4547/255738	6
WP5044	Kynurenine pathway and links to cell senescence	7/642	20/6026	0.00337155422970255	0.0258485824277196	0.0209560262898805	3620/169355/3458/8564/8942/6999/7124	7
WP3942	PPAR signaling pathway	13/642	54/6026	0.0035867758959889	0.0270689493400412	0.02194540515309	2180/2182/51129/335/345/126129/2172/9415/4199/4312/4973/6258/6319	13
WP4478	LTF danger signal response pathway	6/642	16/6026	0.0044791171183448	0.0322897547486647	0.0261780293483781	3552/3553/3569/7097/7124/54210	6
WP4493	Cells and molecules involved in local acute inflammatory response 	6/642	16/6026	0.0044791171183448	0.0322897547486647	0.0261780293483781	3383/3552/3569/3689/6403/7124	6
WP516	Hypertrophy model	6/642	16/6026	0.0044791171183448	0.0322897547486647	0.0261780293483781	467/11072/1839/3458/3552/8013	6
WP4538	Regulatory circuits of the STAT3 signaling pathway	16/642	75/6026	0.00480033997996025	0.0340965325047176	0.0276428246524026	1271/1439/1441/2151/3595/3601/50615/3559/3568/3575/5600/6300/9180/5159/11122/9021	16
WP2884	NRF2 pathway	22/642	116/6026	0.00487644171580586	0.034135092010641	0.0276740857098365	1244/874/2938/2939/1839/3082/23764/4199/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/7042/54657/7364	22
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/642	22/6026	0.00613912872833673	0.0423599882255234	0.0343421937885904	2919/2920/3553/5354/6469/55553/7124	7
WP3967	miR-509-3p alteration of YAP1/ECM axis	6/642	17/6026	0.0063086832850275	0.0429168172770181	0.034793627606082	1277/1281/1909/6678/7058/7291	6
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/642	134/6026	0.00709882681622647	0.0476212965588526	0.038607654614565	9076/24146/51208/1282/1284/94234/11211/3091/3678/5600/6300/4313/4318/4854/4855/8503/6615/6678/7042/7043/7291/7480/7472/7474	24
WP3893	Development and heterogeneity of the ILC family	7/642	23/6026	0.00803096702251896	0.0531363982448857	0.043078871411349	3458/3605/3553/51561/3569/30009/7124	7
WP4723	Omega-3 / omega-6 fatty acid synthesis	5/642	13/6026	0.00838677168776044	0.0547406854755175	0.0443795030988177	2180/2182/54898/3992/9415	5
WP497	Urea cycle and metabolism of amino groups	6/642	18/6026	0.00862624032767138	0.0548220273455958	0.0444454487796919	384/445/1373/2628/4942/5009	6
WP5149	Lipid metabolism in senescent cells	6/642	18/6026	0.00862624032767138	0.0548220273455958	0.0444454487796919	240/84647/50487/283748/7941/5743	6
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	9/642	35/6026	0.00926783398687066	0.0581345950085523	0.0471310217787544	285/597/664/3091/4843/5743/5054/6515/7043	9
WP3929	Chemokine signaling pathway	26/642	152/6026	0.0095551605848468	0.0591684943907821	0.047969227227571	6356/6361/6364/6370/10344/6348/6351/1230/2826/1232/1237/10803/3627/6373/2921/6374/4283/3579/10663/2268/2786/3055/4067/5196/8503/6772	26
WP4210	Tryptophan catabolism leading to NAD+ production	5/642	14/6026	0.01192182641345	0.0719780269712042	0.0583542029710973	3620/8564/8942/10135/6999	5
WP5063	FOXP3 in COVID-19	5/642	14/6026	0.01192182641345	0.0719780269712042	0.0583542029710973	941/50943/3559/3569/3575	5
WP4496	Signal transduction through IL1R	8/642	31/6026	0.0135769042927147	0.0809585774491504	0.0656349369316421	3552/3553/3557/3569/11213/7042/7043/7124	8
WP2374	Oncostatin M signaling pathway	13/642	64/6026	0.0157642337048974	0.0922585470377539	0.0747960760554527	6347/1051/3091/3726/3949/4312/4322/4314/5008/9180/5054/9021/6772	13
WP4389	Bile acids synthesis and enterohepatic circulation 	4/642	10/6026	0.0158539532176679	0.0922585470377539	0.0747960760554527	64240/64241/3949/6555	4
WP5109	Familial hyperlipidemia type 2	5/642	15/6026	0.0163465248184423	0.0939925177060432	0.0762018450183024	335/337/338/3949/255738	5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	10/642	45/6026	0.017795347309814	0.101119444125178	0.0819798043250874	2180/2182/9023/54898/3992/9415/4597/6319/8435/6713	10
WP727	Monoamine transport	6/642	21/6026	0.0191278046783311	0.107427089065511	0.0870935537373216	183/3553/6532/6999/7124/4982	6
WP5122	Prostaglandin and leukotriene metabolism in senescence 	7/642	27/6026	0.019991417852194	0.110986837041491	0.0899795213674066	246/240/3488/5600/5730/9536/5743	7
WP4747	Netrin-UNC5B signaling pathway	10/642	46/6026	0.0206435058925857	0.113304697114988	0.0918586625842332	249/6347/1003/1277/3383/3586/3552/54538/6401/7124	10
WP247	Small ligand GPCRs	5/642	16/6026	0.0217408010457593	0.117986594439345	0.095654381892637	4543/5724/5737/5739/8698	5
WP5130	Th17 cell differentiation pathway	12/642	61/6026	0.0252604557887923	0.135564446066518	0.109905140975798	50943/3091/3458/3605/3553/50615/51561/3559/3569/9021/6772/30009	12
WP4136	Fibrin complement receptor 3 signaling pathway	8/642	35/6026	0.027735639353227	0.146306673166119	0.118614105737814	6347/3627/2921/3569/3689/23643/4843/7124	8
WP3287	Overview of nanoparticle effects	5/642	17/6026	0.0281708501127309	0.146306673166119	0.118614105737814	1001/1282/3569/5743/7124	5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	5/642	17/6026	0.0281708501127309	0.146306673166119	0.118614105737814	249/1594/5251/142680/6696	5
WP4197	Immune response to tuberculosis	6/642	23/6026	0.0296341785608943	0.150518598916428	0.122028808536365	3437/8519/3659/8651/6772/6890	6
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	6/642	23/6026	0.0296341785608943	0.150518598916428	0.122028808536365	1636/59272/183/3569/114548/7124	6
WP364	IL6 signaling pathway	9/642	42/6026	0.0299167401573024	0.150518598916428	0.122028808536365	183/3055/3569/3659/3726/639/9021/6772/7076	9
WP3611	Photodynamic therapy-induced AP-1 survival signaling	10/642	49/6026	0.0311682407856589	0.155015539863769	0.125674579556112	602/2252/1839/3458/3569/3726/5600/6300/4313/7124	10
WP4495	IL-10 anti-inflammatory signaling pathway 	4/642	12/6026	0.031452428378156	0.155015539863769	0.125674579556112	3586/3552/3569/6772	4
WP2873	Aryl hydrocarbon receptor pathway	8/642	36/6026	0.0324537657498492	0.158335038961385	0.128365772024922	1545/2939/3458/3553/3726/8140/7124/54657	8
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	38/642	265/6026	0.0333390564206287	0.161027642511637	0.130548726194462	285/1277/1278/1281/1282/1284/1290/50509/84699/9586/1440/1441/2255/2252/2254/2786/3082/3091/3559/3575/3678/3687/3689/3918/10319/23566/4843/5008/9180/5159/5209/5228/6514/6515/6696/7058/3371/7450	38
WP236	Adipogenesis	19/642	115/6026	0.0338978777501358	0.162105692607085	0.131422725618035	183/1051/1271/56603/1959/3091/3569/10135/5008/80339/6258/6319/5054/8651/9021/6772/7124/7291/7480	19
WP474	Endochondral ossification	11/642	57/6026	0.0357053116731891	0.165932658500538	0.134525332815082	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP4808	Endochondral ossification with skeletal dysplasias	11/642	57/6026	0.0357053116731891	0.165932658500538	0.134525332815082	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	6/642	24/6026	0.0360723170653344	0.165932658500538	0.134525332815082	246/240/8529/57105/1800/2358	6
WP5036	Angiotensin II receptor type 1 pathway	6/642	24/6026	0.0360723170653344	0.165932658500538	0.134525332815082	59272/183/1277/1278/3091/3589	6
WP4298	Acute viral myocarditis	14/642	79/6026	0.0377396144974469	0.171964469832706	0.139415457726418	834/1232/1234/1604/941/3458/3586/3569/3689/4318/64127/8651/6772/7124	14
WP5108	Familial  hyperlipidemia type 1	4/642	13/6026	0.0417038313516651	0.186508801322725	0.151206873906622	51129/335/337/3949	4
WP554	ACE inhibitor pathway	4/642	13/6026	0.0417038313516651	0.186508801322725	0.151206873906622	1636/59272/183/1215	4
WP2895	Differentiation of white and brown adipocyte	5/642	19/6026	0.0443281989362817	0.194641091692946	0.157799904347338	1051/253738/3224/27129/51316	5
WP5066	FOXA2 pathway	5/642	19/6026	0.0443281989362817	0.194641091692946	0.157799904347338	1244/338/2938/2939/4547	5
WP3937	Microglia pathogen phagocytosis pathway	8/642	39/6026	0.0497959427181164	0.21667964263829	0.175667052547551	2207/2209/3055/3689/4067/4688/8503/54210	8
WP2849	Hematopoietic stem cell differentiation	9/642	46/6026	0.0505598116280588	0.218039187646003	0.176769266218401	4261/1437/1440/3552/3553/3569/4778/6688/23650	9
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	6/642	26/6026	0.0514680575169682	0.219991785669873	0.178352281288423	8529/5730/9536/5737/5739/5743	6
WP12	Osteoclast signaling	4/642	14/6026	0.0536166333269511	0.223248568076874	0.180992627927639	1513/8111/6696/4982	4
WP2879	Farnesoid X receptor pathway	4/642	14/6026	0.0536166333269511	0.223248568076874	0.180992627927639	1576/8431/9971/6822	4
WP3971	OSX and miRNAs in tooth development	4/642	14/6026	0.0536166333269511	0.223248568076874	0.180992627927639	249/22943/4854/4855	4
WP98	Prostaglandin synthesis and regulation	8/642	41/6026	0.0641686390283216	0.264901304706661	0.214761436963883	301/1909/3290/5730/9536/5737/5739/5743	8
WP5087	Malignant pleural mesothelioma	50/642	381/6026	0.0661257108480201	0.270356835230705	0.219184358081775	72/285/467/834/6347/6351/29126/1001/1003/1282/1284/1437/1440/115908/1496/2919/3627/6374/22943/2255/2252/2254/8061/11211/1839/3082/3091/3620/3586/3553/3569/3689/3918/10319/4313/4314/4318/114548/5159/5228/5328/6401/6423/6425/8140/6678/6772/7480/7472/7474	50
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/642	15/6026	0.0671694000573181	0.270356835230705	0.219184358081775	1051/2939/4094/23657	4
WP4842	Mammalian disorder of sexual development	4/642	15/6026	0.0671694000573181	0.270356835230705	0.219184358081775	84733/2254/5600/5730	4
WP5222	2q13 copy number variation syndrome	9/642	49/6026	0.0710464955226	0.283598820970379	0.229919933313677	1437/3552/3553/3557/51561/3569/8651/9021/6772	9
WP4595	Urea cycle and associated pathways	5/642	22/6026	0.0771167134021178	0.305306332567401	0.247518700479619	445/1373/4843/4942/5009	5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	11/642	65/6026	0.0802528181075842	0.315139115007831	0.255490358031847	22943/1959/94234/2619/3458/3488/5653/5650/4488/22822/7474	11
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	3/642	10/6026	0.08173319606312	0.315530354512267	0.255807544684675	1116/4318/9021	3
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	7/642	36/6026	0.0818553546334273	0.315530354512267	0.255807544684675	684/8519/10581/10410/3726/5600/6300	7
WP3413	NOTCH1 regulation of endothelial cell calcification	4/642	16/6026	0.0823122663945043	0.315530354512267	0.255807544684675	249/2702/4256/55553	4
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	19/642	128/6026	0.0838515791193283	0.318900100115241	0.25853947312383	116/8553/720/721/1051/2328/3091/3586/3552/3553/3557/3569/3764/5354/6507/6532/6752/7124/11076	19
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/642	23/6026	0.0903063064135688	0.340765203107451	0.276266003173089	285/2022/2200/4053/5054	5
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	9/642	52/6026	0.0960373917139486	0.359581861998738	0.291521091126796	1003/1277/1278/3082/4313/4318/6615/7042/7043	9
WP5111	Familial hyperlipidemia type 4	4/642	17/6026	0.098971163711973	0.367715939022177	0.2981155700474	335/337/3949/4547	4
WP5083	Neuroinflammation and glutamatergic signaling	17/642	115/6026	0.100956388123869	0.37222851499106	0.301774016730248	2893/2898/2906/116443/3458/3586/3552/3553/3569/29968/6507/6515/9021/6772/7042/7043/7124	17
WP3871	Valproic acid pathway	3/642	11/6026	0.103813857348442	0.374194724621624	0.303368067035511	116285/1555/1559	3
WP4583	Biomarkers for urea cycle disorders	3/642	11/6026	0.103813857348442	0.374194724621624	0.303368067035511	445/2628/5009	3
WP4707	Aspirin and miRNAs	3/642	11/6026	0.103813857348442	0.374194724621624	0.303368067035511	283120/4597/5743	3
WP3927	BMP signaling in eyelid development	4/642	18/6026	0.117052065423288	0.418786278514432	0.339519441227784	2255/2296/3625/6469	4
WP4545	Oxysterols derived from cholesterol	6/642	32/6026	0.118371329625947	0.420392295656856	0.340821475393594	134526/9023/1576/9420/3605/3638	6
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/642	12/6026	0.127934333671871	0.441373451167955	0.35783136936794	55509/1437/6688	3
WP5110	Familial hyperlipidemia type 3	3/642	12/6026	0.127934333671871	0.441373451167955	0.35783136936794	335/337/3949	3
WP5112	Familial hyperlipidemia type 5	3/642	12/6026	0.127934333671871	0.441373451167955	0.35783136936794	335/337/3949	3
WP5188	Retinol metabolism	3/642	12/6026	0.127934333671871	0.441373451167955	0.35783136936794	316/1551/9227	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	6/642	33/6026	0.132421413162662	0.451657790451825	0.366169114194353	1636/183/1215/84699/9586/3283	6
WP3646	Hepatitis C and hepatocellular carcinoma	8/642	48/6026	0.132785520174243	0.451657790451825	0.366169114194353	330/1284/3577/3091/3569/4312/4843/5743	8
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	5/642	26/6026	0.136177560987991	0.454503321399826	0.368476050039741	2254/5600/6300/6615/6772	5
WP4655	Cytosolic DNA-sensing pathway	9/642	56/6026	0.136303434014806	0.454503321399826	0.368476050039741	834/843/6351/9560/3627/3553/3569/9636/81030	9
WP3599	Transcription factor regulation in adipogenesis	4/642	19/6026	0.13644509648649	0.454503321399826	0.368476050039741	1051/3569/7124/7291	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	8/642	49/6026	0.144832159130661	0.479136526439104	0.388446742585478	1051/1513/3726/4129/6696/7042/4982/7480	8
WP4008	NO/cGMP/PKG mediated neuroprotection	6/642	34/6026	0.147223133131816	0.483733151718823	0.392173329932227	2906/3458/3553/4843/5593/7124	6
WP3869	Cannabinoid receptor signaling	5/642	27/6026	0.153385783227199	0.491967436753057	0.398849049737686	1557/1559/1576/5600/6300	5
WP4917	Proximal tubule transport	7/642	42/6026	0.15370903607697	0.491967436753057	0.398849049737686	5243/1244/6514/142680/6519/340024/11136	7
WP1434	Osteopontin signaling	3/642	13/6026	0.153803484367933	0.491967436753057	0.398849049737686	4318/5328/6696	3
WP5178	Disorders of fructose metabolism	3/642	13/6026	0.153803484367933	0.491967436753057	0.398849049737686	229/3795/6514	3
WP4787	Osteoblast differentiation and related diseases	14/642	98/6026	0.155838181943827	0.495196328150449	0.401466784509027	2255/2252/2254/11211/5600/6300/4854/4855/5288/8503/6772/7480/7472/7474	14
WP3645	NAD+ biosynthetic pathways	4/642	20/6026	0.157028400254888	0.495717106687	0.40188899136442	952/3620/10135/6999	4
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	5/642	28/6026	0.171441714045083	0.53770355768685	0.435928350135138	9509/1277/1278/60681/4982	5
WP262	Ebstein-Barr virus LMP1 signaling	4/642	21/6026	0.178671693163697	0.543381513046419	0.440531596062478	6364/9260/7124/7185	4
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/642	21/6026	0.178671693163697	0.543381513046419	0.440531596062478	941/3101/3586/6515	4
WP4564	Neural crest cell migration during development	6/642	36/6026	0.178910834680646	0.543381513046419	0.440531596062478	2047/2151/4313/4318/8503/7291	6
WP3935	Leptin-insulin signaling overlap	3/642	14/6026	0.181127171015473	0.543381513046419	0.440531596062478	8503/8651/9021	3
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	3/642	14/6026	0.181127171015473	0.543381513046419	0.440531596062478	3589/3569/652995	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/642	14/6026	0.181127171015473	0.543381513046419	0.440531596062478	941/1493/8503	3
WP5061	Fatty acid transporters	3/642	14/6026	0.181127171015473	0.543381513046419	0.440531596062478	2180/2182/2172	3
WP4331	Neovascularisation processes	6/642	37/6026	0.195701239339146	0.583019427716794	0.472666943686711	3091/4318/4854/4855/7042/7043	6
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	7/642	45/6026	0.197810054595759	0.583019427716794	0.472666943686711	6356/3055/3559/3569/3575/4067/6772	7
WP5053	Development of ureteric collection system	8/642	53/6026	0.197961047920402	0.583019427716794	0.472666943686711	2296/80144/158326/341640/2674/80000/6469/7042	8
WP3591	Sleep regulation	4/642	22/6026	0.201239466444048	0.589082801772577	0.477582657206928	100/134/3569/5730	4
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/642	78/6026	0.204271723900949	0.594356883398546	0.481858473628111	467/22943/8061/11211/283120/5328/6423/6425/7480/7472/7474	11
WP272	Blood clotting cascade	3/642	15/6026	0.209616613755012	0.60264776454566	0.488580077173337	5328/5054/7450	3
WP698	Glucuronidation	3/642	15/6026	0.209616613755012	0.60264776454566	0.488580077173337	54657/79799/7364	3
WP4816	TGF-beta receptor signaling in skeletal dysplasias	8/642	54/6026	0.212354465549283	0.606906549469253	0.492032769756047	2022/2200/3458/3624/5054/6696/6772/7124	8
WP4357	NRF2-ARE regulation	4/642	23/6026	0.224593815924149	0.634379023926106	0.514305321783832	1051/2939/4094/23657	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/642	23/6026	0.224593815924149	0.634379023926106	0.514305321783832	10538/29126/3458/80380	4
WP3298	Melatonin metabolism and effects	5/642	31/6026	0.229921438506188	0.637318778534664	0.516688646866939	1545/1557/1565/406938/4543	5
WP4241	Type 2 papillary renal cell carcinoma	5/642	31/6026	0.229921438506188	0.637318778534664	0.516688646866939	1513/112399/3091/7042/7043	5
WP4565	Neural crest cell migration in cancer	6/642	39/6026	0.230912600918357	0.637318778534664	0.516688646866939	2047/2151/4313/4318/8503/7291	6
WP534	Glycolysis and gluconeogenesis	6/642	39/6026	0.230912600918357	0.637318778534664	0.516688646866939	229/3099/3101/5313/6514/6515	6
WP3644	NAD+ metabolism	3/642	16/6026	0.238994540068975	0.652171541544153	0.528730115406832	952/10135/203447	3
WP4225	Pyrimidine metabolism and related diseases	3/642	16/6026	0.238994540068975	0.652171541544153	0.528730115406832	1373/5009/1890	3
WP3941	Oxidative damage response	6/642	40/6026	0.249221877773242	0.676259364968966	0.548258654829368	715/717/721/728/7124/7185	6
WP2324	AGE/RAGE pathway	9/642	65/6026	0.252161642396017	0.680413817191487	0.551626762548182	249/3091/3625/4322/4313/4316/4318/4843/6772	9
WP4830	GDNF/RET signaling axis	3/642	17/6026	0.268999549288333	0.721815457257027	0.585192001960584	2296/2674/26585	3
WP4900	Purinergic signaling	4/642	25/6026	0.273113016472406	0.728804347824156	0.590858052502094	134/5027/53829/5031	4
WP560	TGF-beta receptor signaling	7/642	50/6026	0.280294196495183	0.743857675314139	0.603062123170665	2022/3458/3624/5054/6696/6772/7124	7
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	6/642	42/6026	0.286959290619411	0.755858314785228	0.612791311104075	330/6347/3569/4318/7124/7185	6
WP4846	SARS-CoV-2 and COVID-19 pathway	2/642	10/6026	0.289291412145149	0.755858314785228	0.612791311104075	59272/340024	2
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	8/642	59/6026	0.289510948727261	0.755858314785228	0.612791311104075	1437/1493/29851/3458/3586/3937/1326/7124	8
WP4172	PI3K-Akt signaling pathway	33/642	280/6026	0.292415729319749	0.759337619685154	0.615612061725787	285/1277/1278/1282/1284/1291/1293/84699/9586/1440/1441/2255/2252/2254/2786/3082/3559/3569/3575/3678/3918/10319/23566/5008/9180/5159/5228/8503/6696/7058/7097/3371/7450	33
WP3877	MYD88 distinct input-output pathway	3/642	18/6026	0.299389046061342	0.773288284746675	0.626922179199658	3552/7097/51311	3
WP2371	Parkinson's disease pathway	5/642	35/6026	0.314869767221935	0.80619677214433	0.653601829002268	120892/5600/6300/9627/9246	5
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	7/642	52/6026	0.315468302143434	0.80619677214433	0.653601829002268	843/3627/3458/9636/5600/6300/7124	7
WP2197	Endothelin pathways	4/642	27/6026	0.32316247441291	0.810333382136821	0.65695547162449	1909/2769/4852/5739	4
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/642	19/6026	0.329941036606627	0.810333382136821	0.65695547162449	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/642	19/6026	0.329941036606627	0.810333382136821	0.65695547162449	2180/7124/7185	3
WP229	Irinotecan pathway	2/642	11/6026	0.330508646544417	0.810333382136821	0.65695547162449	1244/1576	2
WP3630	NAD metabolism, sirtuins and aging	2/642	11/6026	0.330508646544417	0.810333382136821	0.65695547162449	3091/10135	2
WP3930	EDA signaling in hair follicle development	2/642	11/6026	0.330508646544417	0.810333382136821	0.65695547162449	22943/6469	2
WP4271	Vitamin B12 disorders	2/642	11/6026	0.330508646544417	0.810333382136821	0.65695547162449	8029/6947	2
WP5052	Nephrogenesis	2/642	11/6026	0.330508646544417	0.810333382136821	0.65695547162449	8854/80000	2
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/642	28/6026	0.348449267807548	0.849416955155691	0.688641402022267	3082/7042/7043/7474	4
WP2018	RANKL/RANK signaling pathway	7/642	54/6026	0.351370428637246	0.849416955155691	0.688641402022267	1513/3383/4067/6688/6772/4982/7185	7
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	9/642	72/6026	0.35841802986784	0.849416955155691	0.688641402022267	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP3640	Imatinib and chronic myeloid leukemia	3/642	20/6026	0.360455031256934	0.849416955155691	0.688641402022267	5243/5159/11040	3
WP4224	Purine metabolism and related disorders	3/642	20/6026	0.360455031256934	0.849416955155691	0.688641402022267	100/316/7498	3
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3/642	20/6026	0.360455031256934	0.849416955155691	0.688641402022267	3569/4318/6696	3
WP4963	p53 transcriptional gene network	10/642	81/6026	0.360518583451173	0.849416955155691	0.688641402022267	6347/126129/55332/3383/9636/4688/5268/5054/23657/7124	10
WP5098	T-cell activation SARS-CoV-2	10/642	81/6026	0.360518583451173	0.849416955155691	0.688641402022267	941/1493/29851/3458/3594/3595/3605/51561/3937/7124	10
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	2/642	12/6026	0.371023509118927	0.853354070973532	0.691833310236796	8061/7076	2
WP2881	Estrogen receptor pathway	2/642	12/6026	0.371023509118927	0.853354070973532	0.691833310236796	1545/8431	2
WP4211	Transcriptional cascade regulating adipogenesis	2/642	12/6026	0.371023509118927	0.853354070973532	0.691833310236796	1051/1959	2
WP4792	Purine metabolism	2/642	12/6026	0.371023509118927	0.853354070973532	0.691833310236796	100/7498	2
WP5171	Leukotriene metabolic pathway	2/642	12/6026	0.371023509118927	0.853354070973532	0.691833310236796	240/1800	2
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	4/642	29/6026	0.373757983730638	0.855569223421317	0.693629184074817	59272/4939/6772/7097	4
WP4018	Clear cell renal cell carcinoma pathways	10/642	83/6026	0.390275524550127	0.886072013209411	0.71835848079743	229/3091/3099/3101/4199/5159/5313/29968/7042/7043	10
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	3/642	21/6026	0.390752254272473	0.886072013209411	0.71835848079743	5600/6300/7124	3
WP306	Focal adhesion	21/642	183/6026	0.392716315678478	0.886364394732266	0.718595521064407	330/1277/1278/1282/1284/1290/50509/2268/2318/3055/3082/3678/3918/10319/5159/5228/8503/6696/7058/3371/7450	21
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/642	30/6026	0.398983755913673	0.896321647006066	0.726668089105931	3624/6469/6615/7474	4
WP2828	Bladder cancer	5/642	39/6026	0.402996808972043	0.897195577070472	0.727376603836146	1839/4312/4313/4318/1890	5
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/642	13/6026	0.410518059073653	0.897195577070472	0.727376603836146	4312/5743	2
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2/642	13/6026	0.410518059073653	0.897195577070472	0.727376603836146	249/7124	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/642	13/6026	0.410518059073653	0.897195577070472	0.727376603836146	1244/9420	2
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	2/642	13/6026	0.410518059073653	0.897195577070472	0.727376603836146	56624/3091	2
WP692	Sulfation biotransformation reaction	2/642	13/6026	0.410518059073653	0.897195577070472	0.727376603836146	6783/6822	2
WP357	Fatty acid biosynthesis	3/642	22/6026	0.420675326034856	0.911148800335585	0.738688795303122	2180/2182/6319	3
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	3/642	22/6026	0.420675326034856	0.911148800335585	0.738688795303122	1244/5600/6300	3
WP2406	Cardiac progenitor differentiation	4/642	31/6026	0.424030025159226	0.914314741749582	0.741255495109174	290/22943/3624/7070	4
WP69	T-cell receptor signaling pathway	10/642	86/6026	0.43511944865366	0.934056416443189	0.757260514148123	1234/29851/3601/3605/3552/3553/3569/3937/1326/3604	10
WP3925	Amino acid metabolism	9/642	77/6026	0.437415528354706	0.934830531837713	0.757888106883795	384/445/586/875/1373/3034/4942/5009/6999	9
WP5220	Metabolic reprogramming in pancreatic cancer	5/642	41/6026	0.446775922441113	0.937035723630844	0.759675905395389	3099/3949/4199/9122/8140	5
WP4666	Hepatitis B infection	15/642	133/6026	0.448538174980023	0.937035723630844	0.759675905395389	843/84699/9586/1959/1960/3569/5600/6300/4318/8503/6772/7042/7043/7097/7124	15
WP58	Monoamine GPCRs	2/642	14/6026	0.448749873750016	0.937035723630844	0.759675905395389	3274/3352	2
WP3845	Canonical and non-canonical Notch signaling	3/642	23/6026	0.450087552551461	0.937035723630844	0.759675905395389	4237/4854/4855	3
WP4483	Relationship between inflammation, COX-2 and EGFR	3/642	23/6026	0.450087552551461	0.937035723630844	0.759675905395389	4312/51365/5743	3
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3/642	23/6026	0.450087552551461	0.937035723630844	0.759675905395389	3553/3569/10135	3
WP5205	Clock-controlled autophagy in bone metabolism	8/642	70/6026	0.473217654673765	0.96907285010538	0.785649123328324	8553/115908/1513/22943/3569/4982/7480/7474	8
WP3945	TYROBP causal network in microglia	7/642	61/6026	0.478017238924904	0.96907285010538	0.785649123328324	10261/3687/3689/4094/4688/5341/6696	7
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/642	52/6026	0.483431057034695	0.96907285010538	0.785649123328324	602/79092/3575/9021/7124/7185	6
WP395	IL-4 signaling pathway	6/642	52/6026	0.483431057034695	0.96907285010538	0.785649123328324	1051/9046/5600/8651/9021/6772	6
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/642	80/6026	0.48448897825014	0.96907285010538	0.785649123328324	1734/50506/405753/4852/5593/6469/5172/7038/7253	9
WP197	Cholesterol biosynthesis pathway	2/642	15/6026	0.48553960605694	0.96907285010538	0.785649123328324	4597/6713	2
WP2855	Dopaminergic neurogenesis	2/642	15/6026	0.48553960605694	0.96907285010538	0.785649123328324	4929/6469	2
WP4159	GABA receptor signaling	2/642	15/6026	0.48553960605694	0.96907285010538	0.785649123328324	2557/2562	2
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/642	15/6026	0.48553960605694	0.96907285010538	0.785649123328324	2254/5600	2
WP5182	Pro-survival signaling of neuroprotectin D1	2/642	15/6026	0.48553960605694	0.96907285010538	0.785649123328324	330/7124	2
WP4673	Male infertility	11/642	99/6026	0.489359650949063	0.972677824725915	0.788571757214864	5243/338/56603/2346/4313/4318/4843/29968/6648/7124/10537	11
WP1591	Heart development	4/642	34/6026	0.497254443633683	0.98431924702897	0.798009719722735	8553/2255/2296/6469	4
WP205	IL-7 signaling pathway	3/642	25/6026	0.506929965785815	0.990264721569572	0.802829849458169	3559/3575/6772	3
WP3613	Photodynamic therapy-induced unfolded protein response	3/642	25/6026	0.506929965785815	0.990264721569572	0.802829849458169	467/121506/6783	3
WP4950	16p11.2 distal deletion syndrome	3/642	25/6026	0.506929965785815	0.990264721569572	0.802829849458169	8519/5350/7185	3
WP2267	Synaptic vesicle pathway	5/642	44/6026	0.510714977471558	0.990264721569572	0.802829849458169	22999/246213/6507/6581/6532	5
WP2858	Ectoderm differentiation	13/642	120/6026	0.518789359773847	0.990264721569572	0.802829849458169	398/6347/1496/54898/57476/9687/152789/3801/3853/4061/6469/6781/4982	13
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2/642	16/6026	0.520760329769506	0.990264721569572	0.802829849458169	3949/6319	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/642	16/6026	0.520760329769506	0.990264721569572	0.802829849458169	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/642	16/6026	0.520760329769506	0.990264721569572	0.802829849458169	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/642	16/6026	0.520760329769506	0.990264721569572	0.802829849458169	3569/64386	2
WP4912	SARS coronavirus and innate immunity	2/642	16/6026	0.520760329769506	0.990264721569572	0.802829849458169	59272/6772	2
WP3851	TLR4 signaling and tolerance	3/642	26/6026	0.534180347582005	0.999999174117655	0.810721788758347	3569/11213/7124	3
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	3/642	26/6026	0.534180347582005	0.999999174117655	0.810721788758347	2557/2562/8503	3
WP4658	Small cell lung cancer	10/642	93/6026	0.537848883030621	0.999999174117655	0.810721788758347	330/1282/1284/3918/10319/4843/8503/5743/6258/7185	10
WP254	Apoptosis	9/642	84/6026	0.545601805299619	0.999999174117655	0.810721788758347	330/834/843/3002/8739/3659/5551/7124/7185	9
WP3303	RAC1/PAK1/p38/MMP2 pathway	7/642	65/6026	0.547654632879004	0.999999174117655	0.810721788758347	285/9046/5600/6300/4313/4843/79931	7
WP100	Glutathione metabolism	2/642	17/6026	0.554328433833662	0.999999174117655	0.810721788758347	290/2938	2
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2/642	17/6026	0.554328433833662	0.999999174117655	0.810721788758347	3371/7472	2
WP3874	Canonical and non-canonical TGF-B signaling	2/642	17/6026	0.554328433833662	0.999999174117655	0.810721788758347	26585/4017	2
WP4784	Proteoglycan biosynthesis	2/642	17/6026	0.554328433833662	0.999999174117655	0.810721788758347	9469/55790	2
WP5074	Kallmann syndrome	2/642	17/6026	0.554328433833662	0.999999174117655	0.810721788758347	60675/9723	2
WP2643	Nanoparticle-mediated activation of receptor signaling	3/642	27/6026	0.560557581728141	0.999999174117655	0.810721788758347	1277/5600/6300	3
WP286	IL-3 signaling pathway	5/642	47/6026	0.571441263105429	0.999999174117655	0.810721788758347	1232/1439/3055/3568/4067	5
WP4150	Wnt signaling in kidney disease	3/642	28/6026	0.586010579398612	0.999999174117655	0.810721788758347	7480/7472/7474	3
WP4561	Cell migration and invasion through p75NTR	3/642	28/6026	0.586010579398612	0.999999174117655	0.810721788758347	4313/4318/7291	3
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	2/642	18/6026	0.586195857305203	0.999999174117655	0.810721788758347	6615/3371	2
WP4760	PKC-gamma calcium signaling pathway in ataxia	2/642	18/6026	0.586195857305203	0.999999174117655	0.810721788758347	2769/2893	2
WP5193	Cholesterol synthesis disorders	2/642	18/6026	0.586195857305203	0.999999174117655	0.810721788758347	4597/6713	2
WP399	Wnt signaling pathway and pluripotency	9/642	87/6026	0.589535797747875	0.999999174117655	0.810721788758347	8061/11211/3949/120892/4316/5328/7480/7472/7474	9
WP127	IL-5 signaling pathway	4/642	39/6026	0.609143363626596	0.999999174117655	0.810721788758347	1439/3568/4067/6772	4
WP408	Oxidative stress response	3/642	29/6026	0.610501263514148	0.999999174117655	0.810721788758347	3726/6648/7498	3
WP4698	Vitamin D-sensitive calcium signaling in depression	3/642	29/6026	0.610501263514148	0.999999174117655	0.810721788758347	775/1594/2906	3
WP3594	Circadian rhythm genes	16/642	157/6026	0.614684974887539	0.999999174117655	0.810721788758347	100/134/8553/1960/50865/3569/4543/4547/10135/4843/5551/5593/60675/5730/5054/6532	16
WP1584	Type II diabetes mellitus	2/642	19/6026	0.61634348326974	0.999999174117655	0.810721788758347	6514/7124	2
WP325	Triacylglyceride synthesis	2/642	19/6026	0.61634348326974	0.999999174117655	0.810721788758347	56895/2819	2
WP4722	Glycerolipids and glycerophospholipids	2/642	19/6026	0.61634348326974	0.999999174117655	0.810721788758347	56895/80339	2
WP4657	22q11.2 copy number variation syndrome	9/642	89/6026	0.617687516713936	0.999999174117655	0.810721788758347	8854/9076/56603/2255/2296/4942/5625/6469/7450	9
WP4149	White fat cell differentiation	3/642	30/6026	0.63400320880309	0.999999174117655	0.810721788758347	1051/1959/7480	3
WP4313	Ferroptosis	6/642	61/6026	0.644230738201512	0.999999174117655	0.810721788758347	2180/2182/246/875/1803/23657	6
WP2878	PPAR-alpha pathway	2/642	20/6026	0.644775533493386	0.999999174117655	0.810721788758347	335/345	2
WP3580	Methionine de novo and salvage pathway	2/642	20/6026	0.644775533493386	0.999999174117655	0.810721788758347	51074/259307	2
WP2332	Interleukin-11 signaling pathway	4/642	41/6026	0.649373258172047	0.999999174117655	0.810721788758347	3383/3589/9021/6772	4
WP4844	Influence of laminopathies on Wnt signaling	3/642	31/6026	0.656500335622075	0.999999174117655	0.810721788758347	1051/6696/7480	3
WP382	MAPK signaling pathway	21/642	210/6026	0.656588899723622	0.999999174117655	0.810721788758347	775/994/1846/2255/2252/2254/2318/3310/3552/3553/120892/1326/5600/6300/22808/5159/283748/115727/7042/7043/7124	21
WP2359	Parkin-ubiquitin proteasomal system pathway	6/642	62/6026	0.66014054069783	0.999999174117655	0.810721788758347	834/3310/9627/10381/84617/9246	6
WP1423	Ganglio sphingolipid metabolism	1/642	10/6026	0.676128981795692	0.999999174117655	0.810721788758347	6482	1
WP2333	Trans-sulfuration pathway	1/642	10/6026	0.676128981795692	0.999999174117655	0.810721788758347	875	1
WP2436	Dopamine metabolism	1/642	10/6026	0.676128981795692	0.999999174117655	0.810721788758347	4129	1
WP3656	Interleukin-1 induced activation of NF-kB	1/642	10/6026	0.676128981795692	0.999999174117655	0.810721788758347	3552	1
WP5050	TCA cycle in senescence	1/642	10/6026	0.676128981795692	0.999999174117655	0.810721788758347	4199	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/642	10/6026	0.676128981795692	0.999999174117655	0.810721788758347	629	1
WP4823	Genes controlling nephrogenesis	3/642	32/6026	0.677985670806666	0.999999174117655	0.810721788758347	2296/5159/6469	3
WP2586	Aryl hydrocarbon receptor pathway	4/642	43/6026	0.686756606128326	0.999999174117655	0.810721788758347	1545/135112/5743/7124	4
WP410	Exercise-induced circadian regulation	4/642	43/6026	0.686756606128326	0.999999174117655	0.810721788758347	1051/50486/2674/10381	4
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4/642	43/6026	0.686756606128326	0.999999174117655	0.810721788758347	775/2906/116443/8503	4
WP4482	Vitamin D in inflammatory diseases	2/642	22/6026	0.696598776043765	0.999999174117655	0.810721788758347	3569/7124	2
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/642	11/6026	0.710691015320819	0.999999174117655	0.810721788758347	952	1
WP4788	Autosomal recessive osteopetrosis pathways	1/642	11/6026	0.710691015320819	0.999999174117655	0.810721788758347	29887	1
WP4919	Neuroinflammation	1/642	11/6026	0.710691015320819	0.999999174117655	0.810721788758347	4843	1
WP4947	Nitric oxide metabolism in cystic fibrosis	1/642	11/6026	0.710691015320819	0.999999174117655	0.810721788758347	4843	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/642	11/6026	0.710691015320819	0.999999174117655	0.810721788758347	2358	1
WP170	Nuclear receptors	3/642	34/6026	0.717931707717521	0.999999174117655	0.810721788758347	9970/4929/6258	3
WP2361	Gastric cancer network 1	2/642	23/6026	0.720076035423985	0.999999174117655	0.810721788758347	11082/6286	2
WP34	Ovarian infertility	2/642	23/6026	0.720076035423985	0.999999174117655	0.810721788758347	1051/2701	2
WP5064	7-oxo-C and 7-beta-HC pathways	2/642	23/6026	0.720076035423985	0.999999174117655	0.810721788758347	134526/3290	2
WP428	Wnt signaling	9/642	98/6026	0.730717608046868	0.999999174117655	0.810721788758347	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP3527	Pre-implantation embryo	3/642	35/6026	0.736413934978465	0.999999174117655	0.810721788758347	366/55509/94234	3
WP2513	Nanoparticle triggered regulated necrosis	1/642	12/6026	0.741569879520991	0.999999174117655	0.810721788758347	7124	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/642	12/6026	0.741569879520991	0.999999174117655	0.810721788758347	22943	1
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	1/642	12/6026	0.741569879520991	0.999999174117655	0.810721788758347	4597	1
WP4504	Cysteine and methionine catabolism	1/642	12/6026	0.741569879520991	0.999999174117655	0.810721788758347	875	1
WP5173	Disorders of galactose metabolism 	1/642	12/6026	0.741569879520991	0.999999174117655	0.810721788758347	6514	1
WP1539	Angiogenesis	2/642	24/6026	0.742003681201783	0.999999174117655	0.810721788758347	3091/4318	2
WP26	S1P receptor signal transduction	2/642	24/6026	0.742003681201783	0.999999174117655	0.810721788758347	6300/8877	2
WP289	Myometrial relaxation and contraction pathways	12/642	131/6026	0.753252605263439	0.999999174117655	0.810721788758347	133/467/2786/3488/3553/3569/23764/5142/10268/6004/5999/8490	12
WP1422	Sphingolipid pathway	2/642	25/6026	0.76244487384665	0.999999174117655	0.810721788758347	56624/8877	2
WP1528	Physiological and pathological hypertrophy of the heart	2/642	25/6026	0.76244487384665	0.999999174117655	0.810721788758347	183/5600	2
WP581	EPO receptor signaling	2/642	25/6026	0.76244487384665	0.999999174117655	0.810721788758347	8651/6772	2
WP3931	Embryonic stem cell pluripotency pathways	8/642	91/6026	0.767951411659929	0.999999174117655	0.810721788758347	2255/2252/2254/6300/5159/7480/7472/7474	8
WP304	Kit receptor signaling pathway	5/642	59/6026	0.768241741560703	0.999999174117655	0.810721788758347	3726/4067/6615/8651/6772	5
WP47	Hedgehog signaling pathway	1/642	13/6026	0.769157531224935	0.999999174117655	0.810721788758347	6469	1
WP5037	Riboflavin and CoQ disorders	1/642	13/6026	0.769157531224935	0.999999174117655	0.810721788758347	55065	1
WP241	One-carbon metabolism	2/642	26/6026	0.781466917702037	0.999999174117655	0.810721788758347	2346/2745	2
WP4875	Disruption of postsynaptic signaling by CNV	2/642	26/6026	0.781466917702037	0.999999174117655	0.810721788758347	2906/9378	2
WP5038	Mitochondrial immune response to SARS-CoV-2	2/642	26/6026	0.781466917702037	0.999999174117655	0.810721788758347	1636/59272	2
WP2272	Pathogenic Escherichia coli infection	4/642	49/6026	0.781594986745227	0.999999174117655	0.810721788758347	9076/23643/10381/84617	4
WP710	DNA damage response (only ATM dependent)	9/642	103/6026	0.782858642499432	0.999999174117655	0.810721788758347	8061/3949/5288/8503/5328/6648/7480/7472/7474	9
WP4758	Nephrotic syndrome	3/642	38/6026	0.78613111224779	0.999999174117655	0.810721788758347	8542/1493/8029	3
WP3915	Angiopoietin-like protein 8 regulatory pathway	11/642	125/6026	0.79213523369338	0.999999174117655	0.810721788758347	64240/64241/1555/1576/1734/1326/5600/6300/5288/8503/6319	11
WP536	Calcium regulation in cardiac cells	11/642	125/6026	0.79213523369338	0.999999174117655	0.810721788758347	775/2701/2702/2709/10052/2786/3760/5350/6004/5999/8490	11
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/642	14/6026	0.793804274107622	0.999999174117655	0.810721788758347	283120	1
WP4584	Biomarkers for pyrimidine metabolism disorders	1/642	14/6026	0.793804274107622	0.999999174117655	0.810721788758347	1890	1
WP2112	IL-17 signaling pathway	2/642	27/6026	0.799139664579949	0.999999174117655	0.810721788758347	1051/3605	2
WP2525	Trans-sulfuration and one-carbon metabolism	2/642	27/6026	0.799139664579949	0.999999174117655	0.810721788758347	875/29968	2
WP2533	Glycerophospholipid biosynthetic pathway	2/642	27/6026	0.799139664579949	0.999999174117655	0.810721788758347	2819/5320	2
WP5085	Vasopressin-regulated water reabsorption	3/642	39/6026	0.800880091299556	0.999999174117655	0.810721788758347	398/84699/9586	3
WP4630	Measles virus infection	10/642	116/6026	0.805059189800029	0.999999174117655	0.810721788758347	3310/3552/3553/3559/3569/4939/8503/6504/6772/7097	10
WP1772	Apoptosis modulation and signaling	7/642	84/6026	0.805712173922337	0.999999174117655	0.810721788758347	597/330/664/834/843/8739/8794	7
WP3940	One-carbon metabolism and related pathways	3/642	40/6026	0.814767044828531	0.999999174117655	0.810721788758347	64902/586/6648	3
WP4222	Phosphodiesterases in neuronal function	3/642	40/6026	0.814767044828531	0.999999174117655	0.810721788758347	2906/10846/5142	3
WP4481	Resistin as a regulator of inflammation	2/642	28/6026	0.815534209593898	0.999999174117655	0.810721788758347	3569/7124	2
WP1946	Cori cycle	1/642	15/6026	0.815823178968385	0.999999174117655	0.810721788758347	6514	1
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	1/642	15/6026	0.815823178968385	0.999999174117655	0.810721788758347	201294	1
WP4962	Airway smooth muscle cell contraction	1/642	15/6026	0.815823178968385	0.999999174117655	0.810721788758347	952	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/642	15/6026	0.815823178968385	0.999999174117655	0.810721788758347	3091	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	3/642	41/6026	0.827824449038253	0.999999174117655	0.810721788758347	843/3552/7124	3
WP4290	Metabolic reprogramming in colon cancer	3/642	41/6026	0.827824449038253	0.999999174117655	0.810721788758347	229/3101/29968	3
WP49	IL-2 signaling pathway	3/642	41/6026	0.827824449038253	0.999999174117655	0.810721788758347	3559/9021/6772	3
WP3972	PDGFR-beta pathway	2/642	29/6026	0.830721835229435	0.999999174117655	0.810721788758347	5159/6772	2
WP4321	Thermogenesis	8/642	98/6026	0.834071021950166	0.999999174117655	0.810721788758347	2180/2182/126129/84699/9586/5600/6300/5593	8
WP22	IL-9 signaling pathway	1/642	16/6026	0.835494035581643	0.999999174117655	0.810721788758347	6772	1
WP4815	Glycosaminoglycan degradation	1/642	16/6026	0.835494035581643	0.999999174117655	0.810721788758347	3373	1
WP4970	Galanin receptor pathway	1/642	16/6026	0.835494035581643	0.999999174117655	0.810721788758347	3569	1
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5/642	65/6026	0.83678832347332	0.999999174117655	0.810721788758347	941/9076/22943/4311/5329	5
WP195	IL-1 signaling pathway	4/642	54/6026	0.841909252125906	0.999999174117655	0.810721788758347	6347/3552/3553/11213	4
WP143	Fatty acid beta-oxidation	2/642	30/6026	0.844773165688459	0.999999174117655	0.810721788758347	2180/2182	2
WP3858	Toll-like receptor signaling related to MyD88	2/642	30/6026	0.844773165688459	0.999999174117655	0.810721788758347	7097/51311	2
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5/642	66/6026	0.846426107278601	0.999999174117655	0.810721788758347	3638/3949/4597/6319/6713	5
WP1971	Integrated cancer pathway	3/642	43/6026	0.851585567670334	0.999999174117655	0.810721788758347	994/4312/6772	3
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	1/642	17/6026	0.853066885690892	0.999999174117655	0.810721788758347	728689	1
WP5200	Dravet syndrome	1/642	17/6026	0.853066885690892	0.999999174117655	0.810721788758347	5600	1
WP2636	Common pathways underlying drug addiction	2/642	31/6026	0.857757498796486	0.999999174117655	0.810721788758347	72/2893	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/642	31/6026	0.857757498796486	0.999999174117655	0.810721788758347	3283/4318	2
WP4217	Ebola virus infection in host	10/642	123/6026	0.858149621953106	0.999999174117655	0.810721788758347	432/684/93978/2318/3119/3134/3678/8503/9021/6772	10
WP2064	Neural crest differentiation	5/642	68/6026	0.86429227632637	0.999999174117655	0.810721788758347	4488/4854/4855/6615/7291	5
WP3670	Interactions between LOXL4 and oxidative stress pathway	1/642	18/6026	0.868765181478286	0.999999174117655	0.810721788758347	2252	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/642	18/6026	0.868765181478286	0.999999174117655	0.810721788758347	22808	1
WP3995	Prion disease pathway	2/642	32/6026	0.86974228732914	0.999999174117655	0.810721788758347	10538/6688	2
WP4542	Leukocyte-intrinsic Hippo pathway functions	2/642	32/6026	0.86974228732914	0.999999174117655	0.810721788758347	50943/639	2
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	2/642	32/6026	0.86974228732914	0.999999174117655	0.810721788758347	4939/6772	2
WP231	TNF-alpha signaling pathway	7/642	92/6026	0.873051420960995	0.999999174117655	0.810721788758347	330/6347/3569/1326/6401/7124/7185	7
WP4396	Nonalcoholic fatty liver disease	11/642	137/6026	0.877413453104766	0.999999174117655	0.810721788758347	6347/84701/3552/3553/3569/56901/9971/8503/5313/9021/7124	11
WP3529	Zinc homeostasis	2/642	33/6026	0.880792745581601	0.999999174117655	0.810721788758347	7780/169026	2
WP4874	CAMKK2 pathway	2/642	33/6026	0.880792745581601	0.999999174117655	0.810721788758347	3383/4094	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/642	19/6026	0.882788609156538	0.999999174117655	0.810721788758347	8877	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/642	19/6026	0.882788609156538	0.999999174117655	0.810721788758347	3091	1
WP5103	Progeria-associated lipodystrophy	1/642	19/6026	0.882788609156538	0.999999174117655	0.810721788758347	2200	1
WP5194	Synthesis of ceramides and 1-deoxyceramides	1/642	19/6026	0.882788609156538	0.999999174117655	0.810721788758347	8877	1
WP400	p38 MAPK signaling pathway	2/642	34/6026	0.890971560448106	0.999999174117655	0.810721788758347	6772/7042	2
WP4262	Breast cancer pathway	10/642	129/6026	0.893922318699587	0.999999174117655	0.810721788758347	2255/2252/2254/11211/4854/4855/8503/7480/7472/7474	10
WP2507	Nanomaterial induced apoptosis	1/642	20/6026	0.895315613138809	0.999999174117655	0.810721788758347	5551	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/642	20/6026	0.895315613138809	0.999999174117655	0.810721788758347	3002	1
WP4725	Sphingolipid metabolism overview	1/642	20/6026	0.895315613138809	0.999999174117655	0.810721788758347	8877	1
WP4288	MTHFR deficiency	1/642	21/6026	0.906505652493602	0.999999174117655	0.810721788758347	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/642	21/6026	0.906505652493602	0.999999174117655	0.810721788758347	8877	1
WP4905	1q21.1 copy number variation syndrome	1/642	21/6026	0.906505652493602	0.999999174117655	0.810721788758347	2702	1
WP2637	Interleukin-1 (IL-1) structural pathway	3/642	49/6026	0.906511972527501	0.999999174117655	0.810721788758347	3552/1326/5600	3
WP4932	7q11.23 copy number variation syndrome	6/642	86/6026	0.908214176096726	0.999999174117655	0.810721788758347	9076/2200/3224/5313/9246/7472	6
WP2447	Amyotrophic lateral sclerosis (ALS)	2/642	36/6026	0.908951229252707	0.999999174117655	0.810721788758347	834/7124	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/642	36/6026	0.908951229252707	0.999999174117655	0.810721788758347	3488/8744	2
WP623	Oxidative phosphorylation	2/642	36/6026	0.908951229252707	0.999999174117655	0.810721788758347	3002/56901	2
WP2037	Prolactin signaling pathway	5/642	75/6026	0.913635805256989	0.999999174117655	0.810721788758347	3659/4843/8651/9021/6772	5
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	1/642	22/6026	0.916501218038832	0.999999174117655	0.810721788758347	597	1
WP4537	Hippo-Yap signaling pathway	1/642	22/6026	0.916501218038832	0.999999174117655	0.810721788758347	3627	1
WP4686	Leucine, isoleucine and valine metabolism	1/642	22/6026	0.916501218038832	0.999999174117655	0.810721788758347	586	1
WP4148	Splicing factor NOVA regulated synaptic proteins	2/642	37/6026	0.916863345645452	0.999999174117655	0.810721788758347	1600/2898	2
WP4249	Hedgehog signaling pathway	2/642	37/6026	0.916863345645452	0.999999174117655	0.810721788758347	2619/6469	2
WP500	Glycogen synthesis and degradation	2/642	38/6026	0.924126247500877	0.999999174117655	0.810721788758347	3099/3101	2
WP4541	Hippo-Merlin signaling dysregulation	7/642	101/6026	0.924504643770761	0.999999174117655	0.810721788758347	1001/1003/3627/3678/3687/3689/5159	7
WP3658	Wnt/beta-catenin signaling pathway in leukemia	1/642	23/6026	0.925429635430416	0.999999174117655	0.810721788758347	22943	1
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/642	23/6026	0.925429635430416	0.999999174117655	0.810721788758347	5054	1
WP4906	3q29 copy number variation syndrome	3/642	52/6026	0.926415042638332	0.999999174117655	0.810721788758347	3091/8503/200931	3
WP2355	Corticotropin-releasing hormone signaling pathway	5/642	78/6026	0.929435183334042	0.999999174117655	0.810721788758347	8061/3283/3726/4929/6822	5
WP5124	Alzheimer's disease	18/642	226/6026	0.930613983687132	0.999999174117655	0.810721788758347	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP2526	PDGF pathway	2/642	39/6026	0.930788201890138	0.999999174117655	0.810721788758347	5159/6772	2
WP585	Interferon type I signaling pathways	3/642	53/6026	0.932133911524145	0.999999174117655	0.810721788758347	8651/9021/6772	3
WP4521	Glycosylation and related congenital defects	1/642	24/6026	0.933404676918617	0.999999174117655	0.810721788758347	79644	1
WP4925	Unfolded protein response	1/642	24/6026	0.933404676918617	0.999999174117655	0.810721788758347	3553	1
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	1/642	24/6026	0.933404676918617	0.999999174117655	0.810721788758347	2769	1
WP4312	Rett syndrome causing genes	2/642	40/6026	0.936894578577591	0.999999174117655	0.810721788758347	3766/23221	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	5/642	80/6026	0.93848581098072	0.999999174117655	0.810721788758347	183/8503/5320/7124/7474	5
WP2059	Alzheimer's disease and miRNA effects	18/642	229/6026	0.939005750764477	0.999999174117655	0.810721788758347	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP268	Notch signaling	2/642	41/6026	0.942487918553967	0.999999174117655	0.810721788758347	4854/4855	2
WP4806	EGFR tyrosine kinase inhibitor resistance	5/642	82/6026	0.946480837751609	0.999999174117655	0.810721788758347	3082/3569/22808/5159/8503	5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/642	26/6026	0.946890445420399	0.999999174117655	0.810721788758347	1051	1
WP5121	Sphingolipid metabolism in senescence	1/642	26/6026	0.946890445420399	0.999999174117655	0.810721788758347	8877	1
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	2/642	42/6026	0.947608020847714	0.999999174117655	0.810721788758347	72/3689	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/642	42/6026	0.947608020847714	0.999999174117655	0.810721788758347	7042/7043	2
WP61	Notch signaling pathway	3/642	57/6026	0.951147404662742	0.999999174117655	0.810721788758347	3091/4854/4855	3
WP3996	Ethanol effects on histone modifications	1/642	27/6026	0.952573167760416	0.999999174117655	0.810721788758347	8854	1
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	1/642	27/6026	0.952573167760416	0.999999174117655	0.810721788758347	1959	1
WP5102	Familial partial lipodystrophy (FPLD)	1/642	27/6026	0.952573167760416	0.999999174117655	0.810721788758347	5396	1
WP4255	Non-small cell lung cancer	4/642	71/6026	0.953297921914411	0.999999174117655	0.810721788758347	1381/1382/8503/6258	4
WP1403	AMP-activated protein kinase (AMPK) signaling	3/642	58/6026	0.955055947130066	0.999999174117655	0.810721788758347	126129/5209/8503	3
WP2038	Microtubule cytoskeleton regulation	2/642	44/6026	0.956574611003403	0.999999174117655	0.810721788758347	2151/11076	2
WP2583	T cell receptor and co-stimulatory signaling	1/642	28/6026	0.957648684729547	0.999999174117655	0.810721788758347	1493	1
WP183	Proteasome degradation	3/642	59/6026	0.958670642537971	0.999999174117655	0.810721788758347	3134/3458/5698	3
WP5072	Modulators of TCR signaling and T cell activation	3/642	59/6026	0.958670642537971	0.999999174117655	0.810721788758347	3937/1326/8651	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	3/642	60/6026	0.962011493036962	0.999999174117655	0.810721788758347	775/1496/3678	3
WP1601	Fluoropyrimidine activity	1/642	29/6026	0.962181786497408	0.999999174117655	0.810721788758347	1890	1
WP722	Serotonin HTR1 group and FOS pathway	1/642	29/6026	0.962181786497408	0.999999174117655	0.810721788758347	3352	1
WP4566	Translation inhibitors in chronically activated PDGFRA cells	2/642	46/6026	0.964061936736681	0.999999174117655	0.810721788758347	8503/11040	2
WP2034	Leptin signaling pathway	4/642	75/6026	0.965704709624359	0.999999174117655	0.810721788758347	3553/3557/9021/6772	4
WP2363	Gastric cancer network 2	1/642	30/6026	0.966230359628751	0.999999174117655	0.810721788758347	51316	1
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1/642	30/6026	0.966230359628751	0.999999174117655	0.810721788758347	8503	1
WP3888	VEGFA-VEGFR2 signaling pathway	33/642	409/6026	0.970626940890647	0.999999174117655	0.810721788758347	56999/301/6347/1003/79094/1558/22943/1847/1960/2022/24147/6624/1839/3383/6300/4319/4313/4688/4855/4929/8013/5228/5328/5329/5743/27289/57758/6401/9047/6648/6772/8794/81567	33
WP5224	2q37 copy number variation syndrome	6/642	104/6026	0.972050364210286	0.999999174117655	0.810721788758347	1293/6373/27128/3553/7124/54657	6
WP3998	Prader-Willi and Angelman syndrome	1/642	32/6026	0.973075277602537	0.999999174117655	0.810721788758347	2562	1
WP244	Alpha 6 beta 4 signaling pathway	1/642	33/6026	0.975959106728191	0.999999174117655	0.810721788758347	3918	1
WP3981	miRNA regulation of prostate cancer signaling pathways	1/642	33/6026	0.975959106728191	0.999999174117655	0.810721788758347	5159	1
WP422	MAPK cascade	1/642	33/6026	0.975959106728191	0.999999174117655	0.810721788758347	6300	1
WP185	Integrin-mediated cell adhesion	5/642	94/6026	0.977640012089015	0.999999174117655	0.810721788758347	11131/3678/3687/3689/6300	5
WP3286	Copper homeostasis	2/642	51/6026	0.977743952980649	0.999999174117655	0.810721788758347	79689/54739	2
WP313	Hepatocyte growth factor receptor signaling	1/642	34/6026	0.978534486918496	0.999999174117655	0.810721788758347	3082	1
WP4659	Gastrin signaling pathway	6/642	108/6026	0.978934331353374	0.999999174117655	0.810721788758347	330/9076/4316/8503/5743/5054	6
WP2795	Cardiac hypertrophic response	2/642	53/6026	0.981666254408859	0.999999174117655	0.810721788758347	5320/7124	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/642	53/6026	0.981666254408859	0.999999174117655	0.810721788758347	3082/8503	2
WP4223	Ras signaling	10/642	161/6026	0.98232173952023	0.999999174117655	0.810721788758347	2786/22808/5159/8503/51365/84647/5320/50487/283748/115727	10
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3/642	70/6026	0.984004037920247	0.999999174117655	0.810721788758347	5743/7042/7043	3
WP35	G protein signaling pathways	4/642	85/6026	0.984602723260533	0.999999174117655	0.810721788758347	2769/2786/3760/5142	4
WP524	G13 signaling pathway	1/642	37/6026	0.98472218997017	0.999999174117655	0.810721788758347	398	1
WP51	Regulation of actin cytoskeleton	7/642	127/6026	0.986205696608128	0.999999174117655	0.810721788758347	2255/2252/2254/22808/5159/5288/8503	7
WP3584	MECP2 and associated Rett syndrome	2/642	56/6026	0.986321608317076	0.999999174117655	0.810721788758347	2893/6890	2
WP4263	Pancreatic adenocarcinoma pathway	4/642	87/6026	0.986939570587158	0.999999174117655	0.810721788758347	8503/6772/7042/7043	4
WP366	TGF-beta signaling pathway	7/642	130/6026	0.988841479566141	0.999999174117655	0.810721788758347	467/1278/50943/3726/4312/4321/3371	7
WP2853	Endoderm differentiation	6/642	118/6026	0.989867739204055	0.999999174117655	0.810721788758347	22943/1846/1847/3227/6772/30009	6
WP4155	Endometrial cancer	2/642	61/6026	0.991648248186849	0.999999174117655	0.810721788758347	1496/8503	2
WP4971	Phosphoinositides metabolism	1/642	44/6026	0.993094911946446	0.999999174117655	0.810721788758347	5288	1
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	2/642	64/6026	0.993805404907739	0.999999174117655	0.810721788758347	6772/7253	2
WP4540	Hippo signaling regulation pathways	3/642	84/6026	0.995491671826975	0.999999174117655	0.810721788758347	1001/1003/5159	3
WP107	Translation factors	1/642	49/6026	0.996086582949254	0.999999174117655	0.810721788758347	728689	1
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	6/642	134/6026	0.997055777385403	0.999999174117655	0.810721788758347	249/1959/2562/4688/6696/6772	6
WP2857	Mesodermal commitment pathway	5/642	121/6026	0.997397485245662	0.999999174117655	0.810721788758347	8553/22943/2296/3624/6615	5
WP481	Insulin signaling	7/642	156/6026	0.998408407325273	0.999999174117655	0.810721788758347	1326/5600/6300/5288/8503/8651/9021	7
WP3680	Physico-chemical features and toxicity-associated pathways	1/642	58/6026	0.998593623665987	0.999999174117655	0.810721788758347	11211	1
WP4022	Pyrimidine metabolism	2/642	79/6026	0.998645181394306	0.999999174117655	0.810721788758347	956/1890	2
WP2261	Glioblastoma signaling pathways	2/642	82/6026	0.999004779203507	0.999999174117655	0.810721788758347	5159/5288	2
WP673	ErbB signaling pathway	2/642	83/6026	0.999102281892923	0.999999174117655	0.810721788758347	1839/8503	2
WP45	G1 to S cell cycle control	1/642	62/6026	0.999108054564215	0.999999174117655	0.810721788758347	84699	1
WP4685	Melanoma	1/642	63/6026	0.999204068811327	0.999999174117655	0.810721788758347	8503	1
WP437	EGF/EGFR signaling pathway	6/642	157/6026	0.999555412385957	0.999999174117655	0.810721788758347	9046/7837/9047/6456/6772/7291	6
WP4656	Joubert syndrome	1/642	71/6026	0.999680215909931	0.999999174117655	0.810721788758347	6469	1
WP179	Cell cycle	3/642	115/6026	0.999767560103545	0.999999174117655	0.810721788758347	994/7042/7043	3
WP23	B cell receptor signaling pathway	2/642	96/6026	0.999767808934812	0.999999174117655	0.810721788758347	27071/4067	2
WP138	Androgen receptor signaling pathway	1/642	85/6026	0.999935365211557	0.999999174117655	0.810721788758347	8431	1
WP2446	Retinoblastoma gene in cancer	1/642	86/6026	0.999942349815863	0.999999174117655	0.810721788758347	994	1
WP4549	Fragile X syndrome	1/642	101/6026	0.999989654500785	0.999999174117655	0.810721788758347	4318	1
WP4803	Ciliopathies	2/642	138/6026	0.999997379419824	0.999999174117655	0.810721788758347	122481/10309	2
WP4352	Ciliary landscape	5/642	201/6026	0.999998222637986	0.999999174117655	0.810721788758347	875/30845/3934/2040/339488	5
WP411	mRNA processing	1/642	123/6026	0.999999174117655	0.999999174117655	0.810721788758347	10772	1
